Business Context and Reporting Period
Company: Werewolf Therapeutics, Inc. (Ticker: HOWL)
Filing Type: Form 8-K (Current Report)
Date of Report: February 4, 2026
Reporting Period: The filing addresses a deficiency notice received on February 4, 2026, regarding the 30 consecutive business days preceding that date.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The sole financial metric disclosed is the stock price performance:
- Stock Price Deficiency: The closing bid price of the Company's common stock was below $1.00 per share for the last 30 consecutive business days.
- Listing Standard: Nasdaq Listing Rule 5450(a)(1) requires a minimum bid price of $1.00 per share.
Material Changes
The material change reported is the receipt of a deficiency letter from the Nasdaq Listing Qualifications Department. This notice indicates a failure to satisfy the Minimum Bid Requirement for continued listing on the Nasdaq Global Select Market. There is no immediate effect on the listing status as of the filing date.
Outlook, Risks, and Management Commentary
Compliance Timeline:
- Initial Period: The Company has 180 calendar days (expiring August 3, 2026) to regain compliance.
- Requirement: The closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days within this period.
- Secondary Period: If compliance is not met initially, the Company may be eligible for an additional 180-day period, contingent on transferring its listing to the Nasdaq Capital Market and meeting other listing standards.
- Delisting Risk: Failure to cure the deficiency during the compliance periods could result in delisting.
- Appeal Uncertainty: While the Company may appeal a delisting determination to a Hearings Panel, there is no assurance of success or that the stock will remain listed pending the decision.
- Market Transfer: Qualifying for the second compliance period requires meeting the market value of publicly held shares and other initial listing standards of the Nasdaq Capital Market.
The Company intends to actively monitor the closing bid price and evaluate available options to regain compliance. However, management explicitly states there can be no assurance that the Company will be able to regain compliance with the Bid Price Requirement.
Investor Verification Checklist
- Verify the current closing bid price of HOWL stock to assess proximity to the $1.00 threshold.
- Monitor the Company's stock price for 10 consecutive days of trading at or above $1.00 to confirm compliance.
- Review future filings for any announcements regarding a transfer to the Nasdaq Capital Market or an appeal to a Hearings Panel.
- Check the Company's latest 10-K or 10-Q for liquidity and cash runway, as this 8-K does not provide financial health data.